FDA Inspection 1012560 — Saint-Gobain Life Sciences (Hangzhou) Co., Ltd
The FDA completed an inspection of Saint-Gobain Life Sciences (Hangzhou) Co., Ltd on May 11, 2017 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 11, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hangzhou (China)